Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Cash Flow Quality Index
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd cash flow quality index. Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (600671) has a Cash Flow Quality Index of -5.04x as of September 2025. Operating cash flow of CN¥-19.96 Million is below net income of CN¥3.96 Million, suggesting accrual-heavy earnings not yet converted to cash. See financial flexibility index of Hangzhou TianMuShan Pharmaceutical Enter to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (1998–2025)
Cash flow quality index of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd from 1998 to 2025. Historical Cash Flow Quality Index for Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd across 17 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore how well can Hangzhou TianMuShan Pharmaceutical Enter service its debt to assess how comfortably operating cash covers total debt obligations.
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Cash Flow Quality Index by Year (1998–2025)
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd cash flow quality index by year from 1998 to 2025. Year-by-year earnings quality comparison for Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. For the full cash flow conversion analysis, see cash flow conversion of Hangzhou TianMuShan Pharmaceutical Enter.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.67x | CN¥11.79 Million | CN¥17.62 Million | ▲ +139.9% |
| 2024 | -1.68x | CN¥-36.67 Million | CN¥21.87 Million | ▼ -154.2% |
| 2019 | 3.09x | CN¥161.13 Million | CN¥52.06 Million | ▲ +13.5% |
| 2017 | 2.73x | CN¥24.52 Million | CN¥8.99 Million | ▲ +345.8% |
| 2016 | 0.61x | CN¥1.61 Million | CN¥2.63 Million | ▲ +144.0% |
| 2014 | 0.25x | CN¥653.79K | CN¥2.61 Million | ▼ -94.9% |
| 2013 | 4.94x | CN¥12.37 Million | CN¥2.50 Million | ▲ +2292.8% |
| 2011 | -0.23x | CN¥-6.49 Million | CN¥28.80 Million | ▼ -104.8% |
| 2008 | 4.69x | CN¥21.19 Million | CN¥4.52 Million | ▲ +53.2% |
| 2007 | 3.06x | CN¥47.53 Million | CN¥15.53 Million | ▲ +55.2% |
| 2005 | 1.97x | CN¥8.48 Million | CN¥4.30 Million | ▲ +1111.5% |
| 2004 | 0.16x | CN¥1.35 Million | CN¥8.32 Million | ▼ -97.7% |
| 2002 | 7.17x | CN¥21.80 Million | CN¥3.04 Million | ▲ +274.6% |
| 2001 | 1.92x | CN¥10.52 Million | CN¥5.49 Million | ▲ +183.0% |
| 2000 | -2.31x | CN¥-9.67 Million | CN¥4.19 Million | ▼ -170.8% |
| 1999 | 3.26x | CN¥49.09 Million | CN¥15.05 Million | ▲ +3019.5% |
| 1998 | 0.10x | CN¥2.36 Million | CN¥22.54 Million | — |